Skip to main content
Fig. 2 | Journal of Medical Case Reports

Fig. 2

From: Single-agent MOR208 salvage and maintenance therapy in a patient with refractory/relapsing diffuse large B-cell lymphoma: a case report

Fig. 2

Treatment schema. CR complete response; CT computed tomography; DepoCyte liposomal cytarabine; DexaBEAM (dexamethasone, carmustine, etoposide, cytarabine, and melphalan); PET positron emission tomography; PR partial response; R-CHOP rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone; R-ESHAP rituximab, etoposide, methylprednisolone, cytarabine, cisplatin; Z-BEAM-ASCT autologous stem cell transplant conditioned by Z-BEAM (ibritumomab tiuxetan, carmustine, etoposide, cytarabine, and melphalan)

Back to article page

Journal of Medical Case Reports

ISSN: 1752-1947